CSP+K — HRV summary dataset & analysis code (v1.5.1 REPRO READY)

Abstract

Japanese summary 本パッケージは、論文本文の主要臨床解析(患者レベル**≥80% responder**、 非調整ARD+Newcombe 95%CI+Fisher )に整合した HRV支持解析(AAW) の再現アーカイブです。臨床個票は含まず、 HRVの要約データと実行コードのみ を配布します。本文のセッション判定は 階層ルール(同日優先/同日が無ければ次回受診) で定義されており、本パック内では 参照のみ 明記します(臨床データは配布しません)。 English (primary) Title. CSP+K HRV supportive dataset & code — v1.5.1 (REPRO) Scope & alignment. This repository distributes HRV supportive physiology only for the CSP+K program. It aligns with the manuscript’s design posture: the primary clinical endpoint is patient‑level responder = ≥80% of rated sessions “improved” , with session ratings captured via a hierarchical source rule (same‑day pre‑discharge preferred; else first follow‑up explicitly attributing the index session). The clinical endpoints are not distributed here; this pack contains anonymized HRV summary counts and reproducible code implementing design‑based contrasts (AAW = ΔHR<0 ∧ ΔRMSSD>0; Newcombe 95% CIs; two‑sided Fisher). What’s included. data/ HRV summary tables (same‑session pairs; pooled 3‑ and 5‑min; ≤5% artifact; ≤3% HQ subset). code/analysis.py Reproducible analysis producing AAW risk differences (Newcombe 95% CIs) & Fisher p and PNG bar plots . docs/SAP_v1.5.0.md Statistical Analysis Plan (supportive HRV only); CODEBOOK.md ; SOP_excerpt.md . CITATION.cff (Concept DOI) and dual licenses ( LICENSE-CODE , LICENSE-DATA ). How to reproduce. python -m pip install -r code/requirements.txt python code/analysis.py # outputs: #   code/Summary_RD_Newcombe.csv #   code/figures/bar_overall.png, bar_3min.png, bar_5min.png   Analytical posture. No covariate adjustment / no model‑based regression . We report absolute risk differences (ARD) with Newcombe 95% CIs and Fisher’s exact p‑values ; design‑based robustness only. This mirrors the manuscript’s unadjusted, patient‑level primary analysis (responder = ≥80% improved under an IV‑dominant assignment). Versioning & DOIs. Concept DOI (cite in manuscript): 10.5281/zenodo.1739113110 Version DOI (this snapshot): (auto‑assigned on publish; add here after release) The Supplement cites the Version DOI for this exact snapshot; the article cites the Concept DOI . Licensing. Code and data use separate licenses; see LICENSE-CODE and LICENSE-DATA . How to cite. Cite the Concept DOI above and the article: “Association of high‑thoracic epidural priming with higher effectiveness at lower ketamine dose in outpatient care: a single‑center cohort.” (MCPIQO, Original Research). The cover letter and manuscript explicitly present the patient‑level ≥80% responder definition and unadjusted ARD with Newcombe CIs . What’s new in v1.5.1. Fixed the analysis runner; clarified alignment with the manuscript (patient‑level ≥80% , hierarchical rating source); removed S‑ROB1/logistic/IPTW mentions; design‑based RD + Newcombe + Fisher only (no data changes). Package structure (excerpt). CSPK_HRV_Public_v1.5.1_REPRO/   README.md, VERSION, CHANGELOG.md, CITATION.txt, CITATION.cff   code/     analysis.py           # design-based RD (Newcombe 95% CI) + Fisher; outputs CSV & PNGs     requirements.txt     figures/              # outputs appear here   data/     cspk_hrv_pairs_v1.4.csv     hrv_counts_by_length_v1.4.csv     hrv_counts_overall_v1.4.csv   docs/     SAP_v1.5.0.md     SOP_excerpt.md     CODEBOOK.md Keywords. HRV; RMSSD; ketamine; cervical epidural; outpatient; design‑based inference; absolute risk difference; Newcombe CI; Fisher exact; real‑world evidence.    

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Keywords